5 Things Green Organic Dutchman (TSX:TGOD) Is Doing to Be the Market Leader in Organic Cannabis

Find out how Green Organic Dutchman Holdings Ltd (TSX:TGOD) is creating a niche for itself as the markets leading purveyor of organic cannabis products.

edit Businessman using calculator next to laptop

Image source: Getty Images.

Green Organic Dutchman Holdings Ltd (TSX:TGOD) has a unique vision within the market for Canadian cannabis stocks – and that vision is a clear one.

TGOD seeks to become the undisputed market leader for premium organic cannabis products.

Unlike so many other licensed cannabis producers who seem intent on winning the “race to the bottom” as the industry’s lowest cost producer, Green Organic Dutchman’s approach is different.

Rather than being “all about the money” the company feels strongly that by delivering a distinctly superior product, not only will it be able to carve out a niche for itself within what already becoming a crowded marketplace among suppliers and consumers, but it should in theory be able to charge a premium for its product, in turn driving higher margins for its shareholders.

In its most recent investor presentation, TGOD suggest that it expects to achieve a run-rate of production capacity upwards of 200,000 kg annually by Q4 of 2020.

While securing distribution and filling product orders remains a different question altogether, the company already has supply agreements in place with the Ontario Cannabis Retail Corp (OCS) and Velvet Management, one of the country’s largest wine distributors.

Green Organic is hoping that it can capitalize off the recent popularity of health conscious ventures like Whole Foods, which was recently acquired by Amazon.com, Inc. in August of 2017 for more than $13 billion.

But this isn’t just “pie in the sky” type of thinking, either.

Research put forward by the company in its investor presentation suggests that an organic cannabis option would be preferred by 61% of surveyed medical patients and 50% of recreational users. Meanwhile additional research that suggests some of the chemicals and pesticides used in cannabis concentrates run the risk of producing adverse health effects for the drug’s users.

From a financial point of view, there could be certain benefits to the company’s planned business model.

By employing the use of what it calls “hybrid” facilities, the company hopes that it can keep a lid on operating costs while also lowering the requirement for capital investments compared to conventional indoor grow facilities thanks to advanced technologies designed to take advantage of natural lighting and enhanced humidity, environmental and temperature controls.

Looking ahead to the future, Organic Dutchman has already entered into a strategic joint venture dedicated toward the Latin American market, estimated at US$9.8 billion annually and has also created a partnership with multi-billion dollar food processor Symrise that will see two create a U.S.-based beverage innovation company.

Foolish bottom line

Currently trading at a market capitalization of $875 million, the Green Dutchman is valued at considerably less than larger rivals like Canopy Growth Corp, Aurora Cannabis Inc and even Hexo Corp.

Yet prospective investors in the company’s stock shouldn’t exactly be expecting those fortunes to be changing anytime soon.

Make no mistake, this is an interesting play for cannabis investors seeking something a little different and off the beaten path, but until proven otherwise, the market for organic cannabis products – and TGOD stock – shouldn’t be treated any differently than a niche segment within the broader cannabis markets.

Making the world smarter, happier, and richer.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Jason Phillips has no position in any of the stocks mentioned. David Gardner owns shares of Amazon. The Motley Fool owns shares of Amazon.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »